Preferences
Related Series
Infection Control Systems 2012
Breaking Barriers and Getting Value
Market penetration for electronic infection control systems is still shallow (estimated to be 25%–30%), despite the fact that infection preventionists (IPs) are struggling to juggle improved patient care while meeting hefty mandated reporting requirements. Upcoming incentives and penalties from value-based purchasing may drive more widespread use. Which vendors are providers looking at, and how well do those vendors’ solutions work? To answer these questions, KLAS spoke with 119 providers still managing their organization on paper and 202 currently using an infection control system. Research focused on system performance for NHSN reporting, analytics, interfacing, and ability to enhance IPs’ efforts.
Project Manager
Robert Ellis
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.